Publications by authors named "Scott Ernst"

Claim this Profile
I
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial.
Danial Khan Hadi, Kelly J Baines, Behnam Jabbarizadeh, Wilson H Miller, Rahima Jamal, Scott Ernst

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience With Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma.
Scott Strum, Seth Climans, Victoria Purcell, Morgan Black, Eric Winquist, Scott Ernst

J Cutan Med Surg· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer.
Colleen Mackenzie, Jasna Deluce, Morgan Black, Emma Churchman, Eric Winquist, Scott Ernst

Curr Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Eddy Saad, Georges Gebrael, Karl Semaan, Marc Eid, Renée Maria Saliby, Matthew Scott Ernst, D Scott Ernst

Oncologist· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Kosuke Takemura, Matthew S Ernst, Vishal Navani, J Connor Wells, Ziad Bakouny, D Scott Ernst

Eur Urol Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience.
Hanbo Zhang, Nimira S Alimohamed, Naveen S Basappa, Tina Cheng, Michael Chu, D Scott Ernst

Can Urol Assoc J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Bertrand Routy, John G Lenehan, Wilson H Miller, Rahima Jamal, Meriem Messaoudene, Scott Ernst

Nat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Bertrand Routy, John G Lenehan, Wilson H Miller, Rahima Jamal, Meriem Messaoudene, Scott Ernst

Nat Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma.
Matthew S Ernst, Vishal Navani, J Connor Wells, Frede Donskov, Naveen Basappa, D Scott Ernst

Eur Urol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma" [Eur Urol 2023].
Matthew S Ernst, Vishal Navani, J Connor Wells, Frede Donskov, Naveen Basappa, D Scott Ernst

Eur Urol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma.
Vishal Navani, Matthew Ernst, J Connor Wells, Takeshi Yuasa, Kosuke Takemura, D Scott Ernst

JAMA Netw Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience of Vismodegib in Advanced Basal Cell Carcinoma at a Canadian Cancer Center.
Justin Tong, Brandon Mitchell, Kathryn Roth, Diane Logan, Scott Ernst

J Cutan Med Surg· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma.
Adi Kartolo, Jasna Deluce, Wilma M Hopman, Linda Liu, Tara Baetz, Scott Ernst

Curr Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer.
Mark Clemons, Michelle Liu, Carol Stober, Gregory Pond, Mashari Jemaan Alzahrani, Scott Ernst

J Bone Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis.
Daniel V Araujo, J Connor Wells, Aaron R Hansen, Nazli Dizman, Sumanta K Pal, D Scott Ernst

J Geriatr Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218).
F Stephen Hodi, Paul B Chapman, Mario Sznol, Christopher D Lao, Rene Gonzalez, Scott Ernst

Melanoma Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer.
Mark Clemons, Michael Ong, Carol Stober, Scott Ernst, Christopher Booth

Eur J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Mediastinal Germ Cell Tumors-The University of Western Ontario Experience.
Arnon Lavi, Eric Winquist, Shiva M Nair, Joseph L Chin, Jonathan Izawa, Scott Ernst

Curr Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma.
Bimal Bhindi, Jeffrey Graham, J Connor Wells, Ziad Bakouny, Frede Donskov, D Scott Ernst

Eur Urol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline.
Anupam Batra, Scott Ernst, Kylea Potvin, Ricardo Fernandes, Nicholas Power

Can Urol Assoc J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Jeffrey Graham, J Connor Wells, Frede Donskov, Jae Lyun Lee, Anna Fraccon, D Scott Ernst

Eur Urol Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.
Georg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, Denis Soulieres, D Scott Ernst

Eur J Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study.
Johan Hansson, Karen Bartley, Thomas Karagiannis, Jean-Jacques Grob, Rainer Kunstfeld, D Scott Ernst

Eur J Dermatol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas.
John A Thompson, Robert J Motzer, Ana M Molina, Toni K Choueiri, Elisabeth I Heath, D Scott Ernst

Clin Cancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Steven M Yip, Connor Wells, Raphael Moreira, Alex Wong, Sandy Srinivas, D Scott Ernst

Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis